4[5]Sarkar NN. Mifepristone: bioavailability, pharmacokinetics and useeffectiveness. European Journal of Obstetrics, Gynecology and Reproductive Biology, 2002, 101: 113-120.
5[6]Tang Oishan, Schweer Horst, Seyberth HW, et al. Pharmacokinetics of different routes of administration of misoprostol. Human Reproduction,2002, 17: 332-336.
6[7]Danielsson KG, Marions L, Rodriguez A, et al. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol, 1999, 93: 275-280.
4EI-Rafaey H, Hinshaw K, Templeton AA. The abortifacient effects of misoprostol in the second trimester. A randomised comparison with gemeprost in patients pre-treated with mifepristone(RU486).Hum Reprod, 1993 ;8:1744～ 1746.
5Ho PC, Chan YF, Lau W. Misoprostol is as effective as gemeprost in terminationof second trimester pregnancy when combined with mifepristone:a randomised comparative trial. Contraception, 1996;53:281 ～283.
6Urquhart DR,Templeton AA. The use of mifepristone prior to prostalandin induced mid-trimester termination. Hum Reprod,1990;5:883～886.
7Rodger MT,Baird DT.Pre-treatment with mifepristone(RU486)reduces interval between prostaglandin administration and expulsion in second trimester abortion. Br J Obstet Gynaecol,1990;97:41～45.
8El-Rafaey H, Templeton AA. Second trimester induction of abortion by a combination of misoprostol and mifepristone: A randomised comparison between two misoprostol regimens. Hum Reprod, 1995; 10:475～478.
9Ho PC, Ngai SW, Liu KL, et al. Vaginal misoprostol compared with oral misoprostol in Termination of second-trimester pregnancy.Obstet Gynecol,1997;90:735～738.
10Gilbert A, Reid R. A randomised trial of oral versus vaginal administration of misoprostol for the purpose of mid-trimester termination of pregnancy. Aust N Z J Obstet Gynaecol,2001 ;41:407～410.
